37 research outputs found
Helpful and hindering factors for remission in dysthymia and panic disorder at 9-year follow-up: A mixed methods study
Langzeitnachbeobachtung von Peniskarzinompatienten mit histologisch negativen Sentinel-Lymphknoten und initial nicht-palpablen Leistenlymphknoten
Minimal invasives Lymphknoten-Staging bei Patienten mit Peniskarzinom und palpablen inguinalen Lymphknoten
Freiburg Neuropathology Case Conference
Abusive head trauma (AHT) and its most common variant, the shaken baby syndrome (SBS), are predominantly characterized by central nervous system-associated lesions. Relatively little data are available on the value of skeletal and skin injuries for the diagnosis of SBS or AHT. Thus, the present study retrospectively investigated 72 cases of living children diagnosed with the explicit diagnosis of SBS during medico-legal examinations at three German university institutes of legal medicine. The risk of circular reasoning was reduced by the presence of 15 cases with confession by perpetrators. Accordingly, the comparison with the 57 non-confession cases yielded no significant differences. Skeletal survey by conventional projection radiography, often incomplete, was found to be performed in 78% of the cases only. Fractures were found in 32% of the cases. The skull (43%) and ribs (48%) were affected most frequently; only 8% of the cases showed classic metaphyseal lesions. In 48% of the cases, healing fractures were present. Skin lesions (hematomas and abrasions) were found in 53% of the cases with the face (76%), scalp (26%), and trunk (50%) being the major sites. In 48% of the cases, healing skin lesions were observed. Nearly 80% of the cases with fractures also showed skin lesions. The data prove that SBS is frequently accompanied by other forms of physical abuse. Therefore, skeletal survey is indispensable and should always be done completely and according to existing imaging guidelines if child abuse is suspected
Synthesis, Chiral Resolution, and Absolute Configuration of Functionalized Trögerâs Base Derivatives: Partâ II
Seven racemic derivatives of Trögerâs baseâthe 1,7âdibromoâsubstituted derivative 3, the 2,8âdibromoâsubstituted derivative 4, the 2,8âdiiodoâsubstituted derivative 5, the 3,9âdiiodoâsubstituted derivative 6, the 4,10âdibromoâsubstituted derivative 7, its singly debrominated analogue 8, and the 2,8âdiaminoâsubstituted derivative 9 in its Fmocâprotected formâwere synthesized and successfully resolved by (recycling) HPLC on a stationary WhelkâO1 phase at a semipreparative scale. These are valuable functionalized C2âsymmetric building blocks for further applications. Their absolute configurations were determined by Xâray crystal structure analysis and/or by comparison of their quantum chemically calculated circular dichroism and UV/Vis spectra with the experimental obtained spectra
Endurance training is feasible in severely disabled patients with progressive multiple sclerosis
Surprising Substituent Effects on the Self-Assembly of Helicates from Bis(bipyridyl) BINOL Ligands
Cutting edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients
Regulatory macrophages (M regs) were administered to two living-donor renal transplant recipients. Both patients were minimized to low-dose tacrolimus monotherapy within 24 wk of transplantation and subsequently maintained excellent graft function. After central venous administration, most M regs remained viable and were seen to traffic from the pulmonary vasculature via the blood to liver, spleen, and bone marrow. By 1 y posttransplantation, both patients displayed patterns of peripheral blood gene expression converging upon the IOT-RISET signature. Furthermore, both patients maintained levels of peripheral blood FOXP3 and TOAG-1 mRNA expression within the range consistent with nonrejection. It is concluded that M regs warrant further study as a potential immune-conditioning therapy for use in solid-organ transplantation. The results of this work are being used to inform the design of The ONE Study, a multinational clinical trial of immunomodulatory cell therapy in renal transplantation. Copyright © 2011 by The American Association of Immunologists, Inc